|
1
|
Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.
|
Am J Psychiatry
|
2010
|
2.41
|
|
2
|
Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression.
|
Biol Psychiatry
|
2005
|
1.61
|
|
3
|
The His452Tyr variant of the gene encoding the 5-HT2A receptor is specifically associated with consolidation of episodic memory in humans.
|
Int J Neuropsychopharmacol
|
2008
|
1.48
|
|
4
|
Antiplatelet effects of antidepressant treatment: a randomized comparison between escitalopram and nortriptyline.
|
Thromb Res
|
2010
|
1.44
|
|
5
|
Genetic predictors of response to antidepressants in the GENDEP project.
|
Pharmacogenomics J
|
2009
|
1.35
|
|
6
|
The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder.
|
Biol Psychiatry
|
2005
|
1.31
|
|
7
|
Moderation of antidepressant response by the serotonin transporter gene.
|
Br J Psychiatry
|
2009
|
1.25
|
|
8
|
Schizophrenia and bipolar disorder: differences and overlaps.
|
Curr Opin Psychiatry
|
2006
|
1.17
|
|
9
|
Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting.
|
Eur J Clin Pharmacol
|
2004
|
1.16
|
|
10
|
Genetic models of schizophrenia and bipolar disorder: overlapping inheritance or discrete genotypes?
|
Eur Arch Psychiatry Clin Neurosci
|
2005
|
1.13
|
|
11
|
Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression.
|
Br J Psychiatry
|
2009
|
1.13
|
|
12
|
Adverse reactions to antidepressants.
|
Br J Psychiatry
|
2009
|
1.12
|
|
13
|
Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response.
|
Int J Neuropsychopharmacol
|
2008
|
1.10
|
|
14
|
Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project.
|
Neuropsychopharmacology
|
2009
|
1.04
|
|
15
|
Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.
|
J Affect Disord
|
2011
|
1.03
|
|
16
|
Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia.
|
Eur Neuropsychopharmacol
|
2008
|
0.99
|
|
17
|
Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.
|
J Clin Psychiatry
|
2011
|
0.99
|
|
18
|
Two-year outcome of vagus nerve stimulation in treatment-resistant depression.
|
J Clin Psychopharmacol
|
2010
|
0.98
|
|
19
|
Body weight as a predictor of antidepressant efficacy in the GENDEP project.
|
J Affect Disord
|
2009
|
0.96
|
|
20
|
Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants.
|
Biol Psychiatry
|
2010
|
0.96
|
|
21
|
Dissecting the genetic heterogeneity of depression through age at onset.
|
Am J Med Genet B Neuropsychiatr Genet
|
2012
|
0.93
|
|
22
|
Chronic vagus nerve stimulation for treatment-resistant depression increases regional cerebral blood flow in the dorsolateral prefrontal cortex.
|
Psychiatry Res
|
2011
|
0.92
|
|
23
|
Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial.
|
BMC Med
|
2009
|
0.91
|
|
24
|
Association of major depression with rare functional variants in norepinephrine transporter and serotonin1A receptor genes.
|
Am J Med Genet B Neuropsychiatr Genet
|
2009
|
0.90
|
|
25
|
No association of the Val66Met polymorphism of the brain-derived neurotrophic factor with hippocampal volume in major depression.
|
Psychiatr Genet
|
2009
|
0.90
|
|
26
|
Changes in body weight during pharmacological treatment of depression.
|
Int J Neuropsychopharmacol
|
2010
|
0.87
|
|
27
|
The value of HMPAO SPECT in predicting treatment response to citalopram in patients with major depression.
|
Psychiatry Res
|
2009
|
0.86
|
|
28
|
PCLO rs2522833 modulates HPA system response to antidepressant treatment in major depressive disorder.
|
Int J Neuropsychopharmacol
|
2010
|
0.85
|
|
29
|
Contribution of allelic variations to the phenotype of response to antidepressants and antipsychotics.
|
Eur Arch Psychiatry Clin Neurosci
|
2008
|
0.84
|
|
30
|
A variant of the neuronal amino acid transporter SLC6A15 is associated with ACTH and cortisol responses and cognitive performance in unipolar depression.
|
Int J Neuropsychopharmacol
|
2012
|
0.83
|
|
31
|
Population pharmacokinetic analysis of mirtazapine.
|
Eur J Clin Pharmacol
|
2004
|
0.81
|
|
32
|
Association of amygdala volumes with cortisol secretion in unipolar depressed patients.
|
Psychiatry Res
|
2012
|
0.80
|
|
33
|
Influence of 5-HTTLPR polymorphism on resting state perfusion in patients with major depression.
|
J Psychiatr Res
|
2010
|
0.80
|
|
34
|
Variation in GNB3 predicts response and adverse reactions to antidepressants.
|
J Psychopharmacol
|
2010
|
0.80
|
|
35
|
Response-dependent differences in regional cerebral blood flow changes with citalopram in treatment of major depression.
|
J Nucl Med
|
2006
|
0.80
|
|
36
|
Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP.
|
J Affect Disord
|
2010
|
0.79
|
|
37
|
Genome-wide association analysis accounting for environmental factors through propensity-score matching: application to stressful live events in major depressive disorder.
|
Am J Med Genet B Neuropsychiatr Genet
|
2013
|
0.79
|
|
38
|
History of suicide attempts among patients with depression in the GENDEP project.
|
J Affect Disord
|
2009
|
0.79
|
|
39
|
Clinical impact of recently detected susceptibility genes for schizophrenia.
|
Dialogues Clin Neurosci
|
2006
|
0.78
|
|
40
|
Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.
|
World J Biol Psychiatry
|
2011
|
0.78
|
|
41
|
Reduced cardio-respiratory coupling after treatment with nortriptyline in contrast to S-citalopram.
|
J Affect Disord
|
2010
|
0.76
|